US bioelectronics company Cala has formally launched its wristwatch-like Cala kIQ device to relieve hand tremors in people with Parkinson’s disease, adding to its current
With the prospects for its Alzheimer’s drug aducanumab still up in the air, Biogen has moved to shore up its late-stage pipeline with a $3 billion licensing deal with Sage that adds drugs f
The US Food and Drug Administration has approved an over-the-air software upgrade for Infinity implants manufactured by Abbott, giving devices used in Parkinson’s and essential tremor full-
The atrial fibrillation (AFib) detection feature on Apple Watch devices has become the first digital health technology to be qualified under a programme recently introduce
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.